Update on antibacterial soaps: the FDA takes a second look at triclosans.
In December of 2013 the Food and Drug Administration announced it would look further into the safety and efficacy of the biocide triclosan and requested further safety data as part of a new review with the Environmental Protection Agency. The use of triclosan has increased exponentially since its introduction in in 1972, to the point that 75% of commercial soap brands contain triclosan and 76% of a nationwide sample of adults and children excrete triclosan in the urine. This announcement raised an important dialog about the appropriate use of all over the counter biocides. Particular concerns include whether these biocides are more effective than regular soaps, whether they may create new drug resistant bacteria, and whether they may also act as hormone disruptors in humans or the environment.
Kendra Gail
KG
Bergstrom
D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D004342:Drug Hypersensitivity / Q000209:etiology; D024881:Drug Resistance, Bacterial; D052244:Endocrine Disruptors / Q000009:adverse effects; D006794:Household Articles; D006801:Humans; D012574:Schools; D012915:Soaps / Q000009:adverse effects*; D014260:Triclosan / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000891:Anti-Infective Agents, Local; D052244:Endocrine Disruptors; D012915:Soaps; D014260:Triclosan